Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients.

A. Pennisi (Catania, Italy), M. Carone (Pavia, Italy), M. D'Amato (Napoli, Italy), A. Fiore Donati (L'Aquila, Italy), V. Ronsivalle (Catania, Italy), M. Aliani (Pavia, Italy), C. Scognamillo (Milano, Italy), L. Chun (Ridgefield, United States of America), G. Pelaia (Catanzaro, Italy)

Source: International Congress 2019 – COPD treatment: cohorts and real-world studies

Session: COPD treatment: cohorts and real-world studies
Session type: Thematic Poster
Number: 2511

Disease area: Airway diseases

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Pennisi (Catania, Italy), M. Carone (Pavia, Italy), M. D'Amato (Napoli, Italy), A. Fiore Donati (L'Aquila, Italy), V. Ronsivalle (Catania, Italy), M. Aliani (Pavia, Italy), C. Scognamillo (Milano, Italy), L. Chun (Ridgefield, United States of America), G. Pelaia (Catanzaro, Italy). Late Breaking Abstract - Assessment of physical functioning and handling with Tiotropium/Olodaterol (T/O) in patients with COPD requiring long-acting dual bronchodilation in an Italian cohort of patients.. 2511

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Late Breaking Abstract - Real-world evidence of dual bronchodilator therapy using Clinical COPD Questionnaire in 4700 COPD patients Source: Virtual Congress 2020 – Advances in pharmacological treatment of COPD Year: 2020
Late Breaking Abstract - Extrafine single inhaler triple therapy improves quality of life in COPD. Analysis of SGRQ subdomains of the TRIBUTE Study Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018
Late Breaking Abstract - Compare outcomes between COPD patients treated with Tiotropium/Olodaterol (TIO/OLO) and other fixed-dose LAMA/LABAs Source: Virtual Congress 2020 – COPD and the impact of comorbidities Year: 2020
Dual bronchodilation with once-daily QVA149 improves dyspnea and health status and reduces symptoms and rescue medication use in patients with COPD: The IGNITE trials Source: Annual Congress 2013 –New clinical trials of asthma and COPD drugs Year: 2013
Short-term evaluation of a remote patient support program in patients with COPD and frequent exacerbations. ESOPO study Source: International Congress 2015 – Asthma and COPD: overlap and exacerbations Year: 2015
Effect of QVA149 on lung function in the subgroup of patients with a history of exacerbations in the previous year and baseline ICS use from the SHINE study Source: International Congress 2014 – Asthma and COPD devices and treatments Year: 2014
Late Breaking Abstract - Short-term and maintenance oral corticosteroid use for German patients with asthma Source: International Congress 2019 – Powerful cohort studies with/without lung function Year: 2019
Late Breaking Abstract - IMPACT study — single inhaler triple therapy (FF/UMEC/VI) versus FF/VI and UMEC/VI in patients with COPD: healthcare resource utilization and costs — UK Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS Year: 2018
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study Source: International Congress 2019 – Clinical approach to asthma management Year: 2019
Real-world prescribing patterns among newly diagnosed COPD patients receiving ICS: An analysis of UK patient dataset Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
Late Breaking Abstract - Comparative real world effectiveness of triple therapy versus dual bronchodilation in frequently exacerbating patients with COPD Source: International Congress 2018 – COPD exacerbations and bronchiectasis Year: 2018
Late Breaking Abstract - Use of a simple telecoaching pulmonary rehabilitation protocol for COPD patients. Source: International Congress 2019 – Breathing, posture and physical activity in respiratory disease patients Year: 2019
Improving physical activity in patients with severe COPD with urban walking circuits. A randomised trial Source: Annual Congress 2013 –New insights in the assessment of physical activity in daily life in patients with COPD, asthmatics and smokers Year: 2013
Indacaterol/glycopyrronium (IND/GLY) is superior to salmeterol/fluticasone (SFC) in improving the health status of patients with moderate-to-very severe COPD: Results from the FLAME study Source: International Congress 2016 – Pharmacological treatment of COPD: focus on LABA/LAMA combinations Year: 2016
The use of high-freguency chest-wall compression therapy for COPD patients Source: Annual Congress 2013 –The latest insights in respiratory muscles, neuromuscular disease and comorbidities Year: 2013
Single inhaler triple therapy in patients with COPD: patient-reported dyspnoea and health status from the IMPACT Trial Source: International Congress 2018 – Integrating pharmacological and non-pharmacological management in COPD: are we there yet? Year: 2018
QVA149 improves dyspnoea and lung function versus tiotropium in symptomatic patients using LABA/ICS preceding study enrolment: The BLAZE study Source: International Congress 2014 – New clinical evidence for asthma and COPD treatments Year: 2014
Prescribing patterns for UK patients commencing first maintenance therapy for COPD Source: International Congress 2014 – COPD markers Year: 2014
Dual bronchodilation in real-life COPD management: analysis of patients’ characteristics enrolled in COPD Registry in Russia Source: Virtual Congress 2020 – Pharmacological management of COPD Year: 2020
Effectiveness of a 3-week-in-patient-rehabilitation-program in patients with COPD GOLD-stage IV Source: Annual Congress 2013 –The latest insights in pulmonary rehabilitation (part 1) Year: 2013